Bio X Cell, the global leader of functional antibodies for in vivo and emerging preclinical models, unveils a refreshed brand identity which bridges nearly 30 years of scientific leadership in the ...
BrainChild Bio’s initial CAR T-cell therapy program will focus on advancing ongoing clinical trials evaluating safety and efficacy in pediatric brain tumors. SEATTLE--(BUSINESS WIRE)--Seattle Children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback